Combinatorial discovery of tumor targeting peptides using phage display

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Peptides are suitable for cancer imaging and therapy due to their pharmacokinetic properties.
• Current peptide agents are limited in number and target specificity.
• Identifying novel cancer-targeting peptides is a key research objective.

Purpose of the Study:

• To explore novel methods for identifying tumor-avid peptides with improved in vivo targeting capabilities.
• To overcome limitations of in vitro and in situ selection methods for peptide-based cancer targeting.

Main Methods:

• Utilizing affinity selections with complex random peptide libraries displayed on bacteriophage.
• Employing in vivo affinity selections in tumor-bearing animals to identify peptides with optimal in vivo properties.
• Investigating combinatorial chemistry innovations for improved peptide selection.

Main Results:

• In vivo selections successfully identified peptides targeting specific organ vasculature.
• Peptides were identified that specifically bind to or are internalized into tumor cells.
• In vivo selection overcomes limitations of in vitro/in situ methods for peptide stability and targeting.

Conclusions:

• In vivo selection is a powerful strategy for discovering novel tumor-targeting peptides with enhanced in vivo efficacy.
• This approach holds promise for developing advanced peptide-based cancer imaging and therapeutic agents.
• Future work may involve genetically engineered bacteriophage for direct selection of peptides for cancer imaging.